Study Finds No Neurogenesis in Adult Humans’ Hippocampi

Failure to produce evidence of neural precursor cells and immature neurons raises questions about the role of the process in learning and memory.

Written byAshley Yeager
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Stained tissue from a 13-year-old human hippocampus shows a single young neuron (green), surrounded by mature neurons (red) and cell nuclei (blue).COURTESY OF SHAWN SORRELLSNew neurons may not develop in the adult human brain as neuroscientists for years have come to believe. Researchers studying postmortem brain tissue of humans found evidence of neural precursor cells and immature neurons in fetuses, infants, and teenagers, but not in adults over 18 years of age. The findings, published today (March 7) in Nature, contradict two decades of research showing that human adult hippocampi—epicenters of learning and memory in the brain—generate new neurons and raise questions about how scientists study neurogenesis.

“The results highlight our need for new and better tools to study adult neurogenesis to ensure we are using the right markers,” Fred “Rusty” Gage, a neuroscientist at the Salk Institute who generated foundational evidence of adult human neurogenesis in 1998, tells The Scientist. The paper, he notes, reveals gaps in researchers’ understanding of neurogenesis, which additional studies will fill in.

Much of the work on neurogenesis has been done in animals. In the latest study, Shawn Sorrells and Mercedes Paredes of the University of California, San Francisco, and their colleagues wanted to search for evidence of neurogenesis in human brains and test a different technique compared with what had been used in the past. The team collected postmortem and postoperation hippocampal tissue from 59 ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Ashley started at The Scientist in 2018. Before joining the staff, she worked as a freelance editor and writer, a writer at the Simons Foundation, and a web producer at Science News, among other positions. She holds a bachelor’s degree in journalism from the University of Tennessee, Knoxville, and a master’s degree in science writing from MIT. Ashley edits the Scientist to Watch and Profile sections of the magazine and writes news, features, and other stories for both online and print.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies